BEST EVIDENCE TOPIC REPORTS
BET 1. NEBULISED HYPERTONIC SALINE SIGNIFICANTLY DECREASES LENGTH OF HOSPITAL STAY AND REDUCES SYMPTOMS IN CHILDREN WITH BRONCHIOLITIS
| The first 150 words of the full text of this article appear below. |
Report by: Daniel Horner, ST3 Emergency Medicine/Critical Care
Search checked by: Rachel Jenner, Paediatric Emergency Medicine Consultant
Institution: Booth Hall Childrens Hospital, Manchester, UK
A short-cut review was carried out to establish whether nebulised hypertonic saline reduces length of stay and symptoms in children with bronchiolitis. One Cochrane review was found, which addressed this question. This review is summarised. The clinical bottom line is that nebulised hypertonic saline does reduce length of stay and symptoms in children with bronchiolitis.
In [children <2yrs with acute viral bronchiolitis] does [regular administration of nebulised hypertonic saline] lead to reduction in [mortality/morbidity rates or length of hospital stay]
A 3-month-old books in to the emergency department with a 4-day history of a coryzal illness followed by breathing difficulties and decreased oral intake. It is December. Inwardly, you sigh heavily, berating the fact that the bronchiolitis season is upon you and all you
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
